MedKoo Cat#: 319519 | Name: Neomycin B sulfate
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Neomycin is an aminoglycoside antibiotic found in many topical medications such as creams, ointments, and eyedrops. Neomycin belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds. Similar to other aminoglycosides, neomycin has excellent activity against Gram-negative bacteria, and has partial activity against Gram-positive bacteria. It is relatively toxic to humans, and many people have allergic reactions to it. Aminoglycosides such as neomycin are known for their ability to bind to duplex RNA with high affinity.

Chemical Structure

Neomycin B sulfate
Neomycin B sulfate
CAS#4146-30-9 (B sulfate)

Theoretical Analysis

MedKoo Cat#: 319519

Name: Neomycin B sulfate

CAS#: 4146-30-9 (B sulfate)

Chemical Formula: C23H52N6O25S3

Exact Mass: 0.0000

Molecular Weight: 908.87

Elemental Analysis: C, 30.40; H, 5.77; N, 9.25; O, 44.01; S, 10.58

Price and Availability

Size Price Availability Quantity
2g USD 250.00 2 Weeks
10g USD 450.00 2 Weeks
50g USD 950.00 2 Weeks
100g USD 1,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Framycetin sulfate; Neomycin B sulfate; Neomycin B trisulfate; Neomycin trisulfate salt, Framycetin sulphate; Fradiomycin B sulfate
IUPAC/Chemical Name
(2R,3R,4S,5S,6S)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol sulfate
InChi Key
KWBUARAINLGYMG-JGMIRXPNSA-N
InChi Code
InChI=1S/C23H46N6O13.3H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;3*1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;3*(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;;;/m1.../s1
SMILES Code
NC[C@@H]1O[C@@H]([C@@H]([C@H]([C@@H]1O)O)N)O[C@H]2[C@H]([C@@H](O[C@@H]2CO)O[C@@H]3[C@H]([C@@H](C[C@@H]([C@H]3O[C@H]4O[C@@H]([C@H]([C@@H]([C@H]4N)O)O)CN)N)N)O)O.OS(=O)(O)=O.OS(=O)(O)=O.OS(=O)(O)=O
Appearance
Solid powder
Purity
>85% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Framycetin sulfate (Neomycin B sulfate), an aminoglycoside antibiotic, is a potent RNase P cleavage activity inhibitor with a Ki of 35 μM.
In vitro activity:
This report shows that cleavage by RNase P RNA in the absence as well as in the presence of the RNase P protein is inhibited by several aminoglycosides. Among the ones tested, neomycin B was found to be the strongest inhibitor with a Ki value in the micromolar range (35 microM). Studies of lead(II)-induced cleavage of RNase P RNA suggested that binding of neomycin B interfered with the binding of divalent metal ions to the RNA. Reference: Proc Natl Acad Sci U S A. 1999 May 25;96(11):6155-60. https://pubmed.ncbi.nlm.nih.gov/10339557/
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
Water 175.0 192.55
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 908.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Childs-Disney JL, Disney MD. Small Molecule Targeting of a MicroRNA Associated with Hepatocellular Carcinoma. ACS Chem Biol. 2016 Feb 19;11(2):375-80. doi: 10.1021/acschembio.5b00615. Epub 2015 Dec 7. PMID: 26551630; PMCID: PMC4856042. 2. Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA. Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6155-60. doi: 10.1073/pnas.96.11.6155. PMID: 10339557; PMCID: PMC26851.
In vitro protocol:
1. Childs-Disney JL, Disney MD. Small Molecule Targeting of a MicroRNA Associated with Hepatocellular Carcinoma. ACS Chem Biol. 2016 Feb 19;11(2):375-80. doi: 10.1021/acschembio.5b00615. Epub 2015 Dec 7. PMID: 26551630; PMCID: PMC4856042. 2. Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA. Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6155-60. doi: 10.1073/pnas.96.11.6155. PMID: 10339557; PMCID: PMC26851.
In vivo protocol:
TBD